Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 955.99B | 915.14B | 929.04B | 853.45B | 761.32B | 741.02B |
Gross Profit | 363.23B | 330.86B | 337.44B | 302.39B | 243.45B | 221.93B |
EBITDA | 225.82B | 202.17B | 201.54B | 177.20B | 139.07B | 116.29B |
Net Income | 123.64B | 102.68B | 109.17B | 97.13B | 70.23B | 47.16B |
Balance Sheet | ||||||
Total Assets | 1.30T | 1.25T | 1.15T | 1.09T | 965.90B | 921.90B |
Cash, Cash Equivalents and Short-Term Investments | 315.78B | 347.49B | 332.11B | 366.99B | 302.29B | 307.56B |
Total Debt | 338.00M | 30.46B | 272.00M | 241.00M | 545.00M | 90.00M |
Total Liabilities | 281.78B | 266.04B | 250.45B | 272.36B | 249.22B | 231.70B |
Stockholders Equity | 1.02T | 984.02B | 902.21B | 821.19B | 715.87B | 689.45B |
Cash Flow | ||||||
Free Cash Flow | 101.86B | 87.75B | 115.78B | 85.53B | 58.59B | 63.84B |
Operating Cash Flow | 175.51B | 155.52B | 181.70B | 144.49B | 116.31B | 123.64B |
Investing Cash Flow | -85.17B | -67.93B | -159.91B | -57.59B | -57.54B | -59.99B |
Financing Cash Flow | -78.59B | -90.78B | -57.63B | -36.64B | -68.30B | -51.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $19.67B | 18.93 | 7.19% | 8.95% | -6.53% | -50.08% | |
71 Outperform | $13.52B | 14.94 | 13.37% | 1.34% | 5.20% | 100.48% | |
71 Outperform | $14.43B | 22.51 | 25.53% | 1.81% | -0.61% | 15.06% | |
69 Neutral | $9.03B | 9.96 | 16.16% | 4.25% | 2.78% | 1.50% | |
64 Neutral | $26.43B | 19.72 | 18.47% | 2.34% | -7.67% | -0.58% | |
62 Neutral | $10.11B | 9.76 | -0.15% | 2.94% | 2.14% | -32.15% | |
57 Neutral | $10.32B | 27.06 | 3.71% | 2.61% | -1.27% | 48.34% |